COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Announces Proof of Concept in Angioimmunoblastic T-Cell Lymphoma, Validation of CXCL12 as a Therapeutic Target of Tipifarnib in Peripheral T-Cell Lymphoma

02/12/2018 - 18:00

– Two CRs, four PRs (46% ORR) observed in advanced AITL patients in Phase 2 trial of tipifarnib in PTCL – – AITL and other PTCL patients with high CXCL12 expression experienced 50% ORR and 90% clinical benefit with [...]

Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at ASH Annual Meeting

02/12/2018 - 18:00

Results to be Further Discussed in Slide Webcast Today at 8:30 p.m. Pacific Time SOUTH SAN FRANCISCO, Calif., Dec. 02, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the [...]

Bellicum Announces Data Presentation at ASH 2018 Demonstrating Low Rates of Cancer Recurrence in Pediatric AML and ALL Patients Treated with Rivo-cel

02/12/2018 - 16:30

Results show high rates of Relapse Free Survival and Overall Survival in pediatric patients with acute leukemias with median follow-up of 17 months SAN DIEGO, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, [...]

Real-world data show Novartis drug Revolade® improves outcomes for ITP patients compared to other second-line therapies

02/12/2018 - 16:16

Revolade (eltrombopag) showed lower rate of bleeding-related episodes and similar rate of thrombotic events vs. romiplostim, rituximab and splenectomy, in a retrospective analysis of US electronic health records [...]

Zogenix Presents Positive Findings on the Impact of Treatment with FINTEPLA® (ZX008) on Everyday Executive Function in Patients with Dravet Syndrome

02/12/2018 - 15:00

Data Presented During Late-Breaker Session at 72 nd American Epilepsy Society Annual Meeting Additional New Analyses Underscore Psychosocial Burden on Family EMERYVILLE, Calif., Dec. 02, 2018 (GLOBE NEWSWIRE) -- Zogenix [...]

Unum Therapeutics Presents Preliminary Results from Ongoing Phase 1 Study ATTCK-17-01 at the 2018 ASH Annual Meeting

02/12/2018 - 03:25

CAMBRIDGE, Mass., Dec. 01, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), today announced preliminary results from the ongoing Phase 1 ATTCK-17-01 study, testing ACTR087 in combination with SEA-BCMA in [...]

Correction new weekday: Oncology Venture: Notice to Convene Extraordinary General Meeting

01/12/2018 - 22:58

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLING NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING KALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes herved til ekstraordinær generalforsamling i Oncology Venture A/S (" [...]

BeiGene Announces Clinical Results of Zanubrutinib in Mantle Cell Lymphoma From Two Presentations at the 60th American Society of Hematology Annual Meeting

01/12/2018 - 21:45

Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm PST CAMBRIDGE, Mass. and BEIJING, China, Dec. 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage [...]

Novartis announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers

01/12/2018 - 20:31

In the updated analysis from ELIANA, Kymriah demonstrated an 82% remission rate within 3 months in pediatric patients with r/r ALL; relapse-free survival was 62% at 24 months, with median duration of remission still not [...]

Bellicum Announces Interim Results Showing Rimiducid Controlled GvHD in Patients Treated with Rivo-cel Following a Stem Cell Transplant

01/12/2018 - 20:00

Experience to date in clinical study shows high clinical response rates for patients with visceral GvHD or GvHD that was refractory to standard of care treatment SAN DIEGO, Dec. 01, 2018 (GLOBE NEWSWIRE) -- Bellicum [...]

Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A

01/12/2018 - 18:00

Initial Data from Shire Collaboration Identifies Key Biomarkers That Affect Bleeding Patterns, Response to Treatment for Hemophilia A Data from iPATH Collaboration to be presented at the American Society of Hematology's [...]

Catalyst Biosciences Announces Updated Positive Interim Data from Its Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors

01/12/2018 - 18:00

Results demonstrate efficacy of subcutaneous prophylaxis with MarzAA, Catalyst’s high potency engineered FVIIa Data presented at 60 th American Society of Hematology Annual Meeting & Exposition SOUTH SAN FRANCISCO, [...]

Bellicum Announces Favorable Interim Event-Free Survival Data for Rivo-cel Treated Patients in Presentation at ASH 2018

01/12/2018 - 18:00

Interim results suggest rivo-cel outcomes were comparable to a control study of transplants from matched unrelated donors, a requirement for product registration in Europe Company on track to report final results in [...]

Novartis announces new crizanlizumab (SEG101) data analysis in sickle cell disease, and investment in SENTRY clinical program

01/12/2018 - 16:16

New post-hoc analysis of SUSTAIN study, presented at ASH 2018, highlights results among patients who were treated per protocol compared with all randomized patients Crizanlizumab, a monthly infusion being investigated [...]

Oncology Venture: Notice to Convene Extraordinary General Meeting

01/12/2018 - 13:14

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLING NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING KALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes herved til ekstraordinær generalforsamling i Oncology Venture A/S (" [...]

Financière de Tubize SA : Buy-back of own shares

01/12/2018 - 08:01

FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, general manager, aspijcke@icloud.com Buy-back of own shares Regulated information 1 st December 2018 The board of directors [...]

Financière de Tubize SA : Rachat d'actions propres

01/12/2018 - 08:01

FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, aspijcke@icloud.com Rachat d'actions propres Information réglementée 1 er décembre 2018 Le Conseil d'administration de [...]

Cooper Hotel Receives ConventionSouth’s Annual Readers’ Choice Award

01/12/2018 - 02:09

Cooper Hotel recognized for commitment to professionalism, creativity and service DALLAS, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Cooper Hotel is honored to accept the ConventionSouth 2018 Readers’ Choice Award. This is the [...]

Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring

01/12/2018 - 01:29

TORONTO, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“ Canopy Growth ”) and Canopy Rivers Inc. (“ Canopy Rivers ”) (TSXV: RIV) are pleased to announce the closing of the [...]